Community/research information only未获 FDA/EMA 批准

Community protocol · DSIP

DSIP: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: Emideltide · Delta sleep-inducing peptide

Sources checked: 27 August 2026

重要安全与责任声明

本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

DSIP

研究关注睡眠和压力调节；证据及安全性数据不足。

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amounts, timing and cycles

Community/research information only

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amount status

Different amounts circulate online; no regulator-confirmed safe or effective dose exists.

Profile evidence level: preclinical.

Timing

Community claims about time of day, fasting windows or training intervals are not validated clinical standards.

No individual recommendation.

Cycle/duration

Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.

No individual recommendation.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

复配与 U-100 换算

复配计算器

For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.

复配计算器

Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.

Total vial amount (mg)Fluid added (ml)Amount to calculate (µg)

Concentration

3,333.33 µg/ml

Calculated volume

0.06 ml

U-100 units

6 U

Calculated portions per vial

Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.

Mechanism and research questions

Synthetic nonapeptide

DSIP is classified as “Synthetic nonapeptide”. 研究关注睡眠和压力调节；证据及安全性数据不足。 This describes the investigated pathway but does not validate a community use, amount, route or combination.

睡眠调节肽

这项研究考察某肽如何影响动物模型中的睡眠阶段和入睡过程,类似于测试某个信号对昼夜节律的影响。在实验室中测量睡眠时长和睡眠模式。

抗焦虑信号传导

这项研究考察某肽如何影响动物模型中的应激和焦虑反应,类似于观察动物在陌生环境中是否保持更加平静。测量指标包括行为测试和应激激素水平。

神经内分泌信号传导

这项研究考察神经系统与激素分泌腺体之间如何相互沟通,类似于连接大脑与远端器官的双向电话线路。研究人员通常同时测量血液中的激素水平和神经系统活动标志物。

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

睡眠优化论坛

用户使用睡眠追踪设备比较使用不同肽后主观感受到的睡眠质量和入睡时间。日常可穿戴设备数据和论坛报告无法替代对照的睡眠实验室研究。

生物黑客与长寿论坛

用户比较自行组合的肽方案,以期影响衰老过程或能量水平,常常依据血液检测或主观幸福感量表。个人自我实验和营销承诺无法取代对照的长期人体研究。

来源与纯度讨论

人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。

Adverse effects and risk boundaries

中枢神经系统影响可能包括疲劳、躁动、头痛、眩晕、睡眠或情绪变化。未获批物质的相互作用及长期神经精神安全性不明确。
Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

妊娠、癫痫、严重精神或神经系统疾病，以及合并镇静或兴奋药物，均需医学评估。
Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

研究可根据终点评估认知、睡眠、情绪、生命体征及不良事件；每日主观感受不能替代标准化测量。
Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

临床前

证据和安全性数据不足以支持疗效方面的声明。

Published evidence

现有数据主要来自动物或细胞模型;缺乏可靠的人体有效性和安全性数据。

DSIP主要与睡眠和应激调节相关,不同于更专注于细胞衰老的Epitalon。

Storage and stability

The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

未获 FDA/EMA 批准

没有 FDA 或 EMA 批准的药品；有效性与安全性尚未确立。

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Comparisons and related profiles

Combinations / stacks

Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Sources and evidence layers

Primary sources and official registries take priority. The community reference is labelled separately.

Primary/technical sourceFDA: 2026 peptide advisory review
Community referenceDSIP — Peptide Dosing Protocols

Back to all 64 profiles Open scientific atlas profile